1 Min Read
Aug 24 (Reuters) - Neuren Pharmaceuticals Ltd
* HY operating revenue $19,000, down 93.8 percent
* HY net loss attributable to members $3.6 million versus loss of $7.4 million Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.